ZEPATIER (elbasvir/grazoprevir) Patient Assistance Program
Don’t let the high cost of brand HCV genotype 1/4 therapy disrupt your treatment. We help eligible patients access Zepatier (elbasvir/grazoprevir) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Zepatier (elbasvir/grazoprevir) is FDA-approved for treatment of chronic HCV genotypes 1 and 4 in adults. Single tablet once daily for 12–16 weeks. NS5A + NS3/4A protease inhibitor combination.
- Without assistance, Zepatier costs commonly run approximately $20,000–$28,000 per 12-week course.
- Through AffordMyPrescriptions, qualifying patients can access Zepatier for a flat $69.95 per month.
- Other HCV DAAs: Mavyret (pangenotypic 8-week), Epclusa (pangenotypic 12-week, authorized generic available), Harvoni (genotype 1, authorized generic available — formerly $94,000/course, now lower), Vosevi (salvage), Sovaldi (used in combinations). Mavyret and Epclusa generally preferred (pangenotypic). Zepatier appropriate for genotypes 1/4.
What Is Zepatier Prescription Assistance Program?
Zepatier PAP for HCV patients.
Eligibility, hepatology/ID coordination.
AffordMyPrescriptions eliminates that burden. $69.95/month advocacy.
Pharmacy Price Comparison
- Zepatier $20,000–$28,000/course. PAP and other HCV options help:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$27,000/course | Save substantially |
| CVS Pharmacy | ~$28,000/course | Save substantially |
| Walmart | ~$21,000/course | Save substantially |
| Costco | ~$20,500/course | Save substantially |
Authorized generic Epclusa/Harvoni | Lower | Generic alternatives |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Zepatier Prescription Program?
PAP at no cost. Medicaid expanded HCV coverage in most states. Other DAAs (Mavyret, Epclusa with authorized generic) often comparably effective.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Zepatier:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $20,000–$28,000 per course per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Zepatier assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Zepatier Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Zepatier:
Zepatier is direct-acting antiviral (DAA) for chronic HCV genotypes 1 and 4. Highly effective — cure rates 95%+ in most patients. Era of HCV DAAs (since 2014) has revolutionized HCV treatment — most patients now achievable cure with 8–12 week oral regimens.
How Zepatier Works:
HCV replication requires viral proteins NS5A (replication complex assembly) and NS3/4A (protease — viral polyprotein processing). Direct-acting antivirals target these proteins.
Elbasvir is NS5A inhibitor. Grazoprevir is NS3/4A protease inhibitor. Combination provides robust antiviral effect — cure rates 95%+. Resistance-associated substitutions (RAS) testing recommended for genotype 1a; presence of NS5A RAS may require ribavirin addition or alternative regimen.
Form and use:
Zepatier 1 tablet once daily for 12 weeks (some patients 16 weeks with ribavirin).
Generic availability:
No generic Zepatier. Other HCV DAAs with authorized generics: Epclusa (sofosbuvir/velpatasvir authorized generic — pangenotypic 12-week), Harvoni (ledipasvir/sofosbuvir authorized generic — genotype 1). Mavyret (glecaprevir/pibrentasvir — pangenotypic 8-week) brand. Choice based on genotype, treatment history, cirrhosis status, drug interactions.
Warnings:
Hepatitis B reactivation (screen for HBV before HCV treatment; if HBsAg+ or HBcAb+, monitor or co-treat HBV), ALT elevations (especially in cirrhotic patients with NS5A polymorphisms), drug interactions (CYP3A — many; OATP transporter), contraindicated in moderate/severe hepatic impairment.
FAQ (Frequently Asked Questions)
Cost ?
$20,000–$28,000/course. PAP for uninsured. Most insurance covers HCV treatment.
Cure rate?
95%+ for HCV genotypes 1 and 4 with Zepatier. Sustained virologic response = cure.
Zepatier vs other DAAs?
Mavyret pangenotypic 8 weeks (often preferred for treatment-naive). Epclusa pangenotypic 12 weeks (authorized generic available). Harvoni genotype 1 (authorized generic). Zepatier genotype 1/4 specifically. Hepatology guidance for individual patients.
Drug interactions?
Significant — CYP3A4 inhibitors/inducers, OATP transporter, statins (lovastatin/simvastatin contraindicated), tacrolimus levels rise. Hepatology coordinates.
Medicaid coverage?
Most state Medicaid programs now cover HCV DAAs without prior fibrosis-stage restrictions. AASLD/IDSA guidelines call for universal access.
Denied?
Authorized generic Epclusa/Harvoni often cheaper. Manufacturer copay programs. Mavyret if pangenotypic appropriate. Medicaid.
Take Control of Your Medication Costs
PAP and authorized generic alternatives help with HCV treatment access. Cure is the goal. Check eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.